Yalcin, A. D. Et Al. 2013. Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels. EXPERT OPINION ON BIOLOGICAL THERAPY , vol.13, no.9 , 1335-1341.

Yalcin, A. D., ÇİLLİ, A., Bisgin, A., Strauss, L. G., & Herth, F., (2013). Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels. EXPERT OPINION ON BIOLOGICAL THERAPY , vol.13, no.9, 1335-1341.

Yalcin, Arzu Et Al. "Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels," EXPERT OPINION ON BIOLOGICAL THERAPY , vol.13, no.9, 1335-1341, 2013

Yalcin, Arzu D. Et Al. "Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels." EXPERT OPINION ON BIOLOGICAL THERAPY , vol.13, no.9, pp.1335-1341, 2013

Yalcin, A. D. Et Al. (2013) . "Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels." EXPERT OPINION ON BIOLOGICAL THERAPY , vol.13, no.9, pp.1335-1341.

@article{article, author={Arzu Didem Yalcin Et Al. }, title={Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels}, journal={EXPERT OPINION ON BIOLOGICAL THERAPY}, year=2013, pages={1335-1341} }